Skip to main content

Posts

New Players in the treatment of Community-Acquired Pneumonia (CAP): Ceftaroline and Corticosteroids by Steven P. LaRosa, M.D.

The treatment of community-acquired pneumonia (CAP) has been for many years unchanged and boring. We give a macrolide to cover Legionella, Chlamydophila, and Mycoplasma and Ceftriaxone, a 3 rd generation Cephalosporin, to cover the dreaded Pneumococcus and Haemophilus influenzae . Data from recent clinical trials would suggest a role for Ceftaroline and corticosteroids. Ceftaroline Ceftaroline, a “5 th Generation Cephalosporin” has a similar spectrum of action as the CAP workhouse drug Ceftriaxone but also has activity against MRSA. There have now been 3 Phase III trials of Ceftaroline vs. Ceftriaxone in CAP patients with a moderate severity of illness as indicated by PORT scores III and IV. The primary efficacy variable was clinical response at days 8-15 in the modified intent to treat population (patients who were randomized and received some study drug). In a meta-analysis (Antimicrob Chemother 2016; 71: 862–870), A superior clinical response was observed with Ceftaroli...

Fluid Resuscitation in Septic Shock: "There is nothing normal about Normal Saline" by Steven P. LaRosa, M.D.

So let me take you way back (at least for me) to medical school and residency. One of the first practical things that we got taught was about fluid management of patients. Hours were spent on teaching us the difference between a deficiency in free water requiring hydration versus volume depletion. We were taught that if a patient was intravascularly volume depleted that you needed to provide a solution isotonic with plasma. If you were a "flea" or aspiring "flea" (see Internal Medicine physician) this was done with 0.9% sodium chloride or what is known as Normal saline (NS) and if you were a surgical type with Lactated Ringers solution (LR). I cannot recall during residency or Chief residency a whole lot of discussion as to the merits of one type of crystalloid over the other and it felt like this was nothing more than a cultural phenomenon. Fast forward now to my early days as an Infectious Disease Attending and aspiring Sepsis Researcher. I would attend ma...

Fluid Resuscitation in Septic Shock: "Sometimes we go too far" by Steven P. LaRosa, M.D.

In the classic movie "Apocalypse Now" Willard (Martin Sheen) is staring at a number of decapitated heads on sticks on land under the control of the now psychotic Colonel Kurtz (Marlon Brando). An American photo journalist played by Dennis Hopper tries to explain away the murdering by saying "The heads. You're looking at the heads. Sometimes he goes too far. He's the first one to admit it." This is undoubtedly what has happened in Critical Care with fluid resuscitation in septic shock. We were all swept away by the Early Goal Directed Therapy data with early aggressive resuscitation being associated with improved outcomes. Hell, long before the Rivers EGDT trial my mentor, Charles J. Fisher, Jr. M.D. , emphasized the importance of providing adequate resuscitation to improve organ function and decrease vasopressor needs when he said "You can't drive a car on empty tank". We had seen countless patients transferred to the MICU at Cleveland Clinic ...

Let"s Get Real About "Penicillin Allergies"

I just came off a very busy clinical stretch at my hospital where I also serve as the Medical Director of Antimicrobial Stewardship. I was a bit disappointed in myself because I felt that I was accepting a large number of penicillin allergies at face value resulting in the use of more Carbapenems. Now that the dust has settled clinically (at least for a couple of days), I have had the chance to reflect on this as well as consult the literature in an effort to "mend my ways". Fortunately, Trubiano, Adkinson and Phillips just published an excellent clinical review on Penicillin Allergy in JAMA 2017;318 (1):82-83. They mad some excellent points which I think are important to highlight. 1) 10% of all inpatients will claim to have a penicillin allergy but only 10% of these or 1% of the population will have a true allergy. 2) If a patient has had a true IgE hypersensitivity reaction to penicillin these antibodies are often gone a decade after the reaction. 3) For patients who...
"Sepsis Musings" By Steven P. LaRosa, M.D. The data are clear that the mortality of patients who develop sepsis in the hospital is higher than those who present to the ED with sepsis. This undoubtedly is due to delayed identification. It is of critical importance to have an "Early Warning System" incorporated into the EMR to flag patients with sepsis. A review of the literature indicates that the National Early Warning Score (NEWS) has the best combination of sensitivity and specificity for this purpose. SIRS criteria are too sensitive leading to "alert fatigue"while the newly coined qSOFA has great specificity but poor sensitivity. Of all the components of the early sepsis bundle is appears that the early administration of effective antibiotics is the most important. It is critical the ID physicians play a key role in a sepsis team. There is an accumulating data that hyperchloremic "normal saline" is associated with worse outcomes and incre...

"I'm Throwing you (ID) Pearls Here" by Steven P. LaRosa, M.D.

Prior to me employed by a non-academic teaching hospital I spent 11 years teaching Infectious Disease to medical students, Internal Medicine residents and ID fellows at 3 different academic teaching hospitals. I had a vast array of clinical pearls that I would share on teaching rounds. In my last 5 years in a non-teaching setting I am often amazed that no one ever taught physicians who are Board Certified in Internal Medicine these important teaching points. I thought it might be useful to share some of my favorite ID teaching points or "pearls" in this blog. 1) oral Beta lactam agents are not adequate treatment of bacteremia 2) Beta-lactam- beta lactamase drugs (Unasyn, Zosyn) and Carbapenems (Ertapenem and Meropenem) have perfectly adequate anaerobic coverage and do not require the addition of Metronidazole 3) Oral vancomycin has no bioavailability 4) Vancomycin is inferior to Beta lactam drugs for the treatment of serious MSSA infections 5) When awaiting sensiti...

Euphrates Trial Results: Let the Dicing and Slicing Begin! by Steven P. LaRosa, M.D.

This week the much anticipated results of the Euphrates Trial were presented in Vicenza. For those of you not familiar with this acronym, this was the first blinded randomized controlled trial of the Immobilized Polymyxin (PMX) Filter in the treatment of patients with septic shock. This filter known as TORAYMYXIN has been used for years in thousands of patients in Japan and Europe. The mechanism of action is the removal of endotoxin believed to be a noxious mediator of sepsis. This clinical trial was novel in that it included a biomarker, the endotoxin activity assay (EAA), as an inclusion criteria to select patients who had the target of the therapy. Patients were included if they had septic shock and a high EAA level of > or = 0.6. Patients randomized to the treatment arm had hemoperfusion of their blood over the PMX filter during 2 2hour sessions 24 hours apart. Patients in the sham group had the usual standard of care but had a venous catheter layed over their skin...